Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR); Correction, 24151-24152 [2019-10871]

Download as PDF 24151 Federal Register / Vol. 84, No. 101 / Friday, May 24, 2019 / Notices Background and Brief Description Falls are the leading cause of both fatal and non-fatal injuries among older adults, defined as age 65 and older. From 2007 to 2016, fall death ageadjusted rates increased by 31% with almost 30,000 older adults dying as the result of a fall in 2016. The economic consequences of falls are significant and growing as the population ages, with medical costs of older adult falls estimated at $50 billion. CDC created the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) initiative to guide health care providers’ fall prevention activities in the primary care setting. This new data collection effort is an essential component to determine the impact of CDC’s Stopping Elderly Accidents, Deaths, and Injuries (STEADI) initiative on falls, emergency department visits, and hospitalizations due to falls. It will help CDC determine the impact of less resource intense versions of STEADI, and evaluate the process of implementing STEADI fall prevention initiative in a primary care setting to provide context for the impact evaluations. The study population will be limited to adults 65 and older who have an outpatient visit during the they can accurately recall and report the information during the 12-month period for the patient surveys. The process evaluation interviews will be used to understand the attitudes of clinical staff towards the implementation process, barriers and facilitators to implementation, and the implementation fidelity to core components of the STEADI initiative. Descriptive statistics and cross tabulations will be used to describe quantitative data from the patient survey and process evaluation data. Risk ratios of the effect of the intervention on post-intervention falls will be calculated comparing intervention and control groups while controlling for demographic, health, attitude, and behavior variables. The data collected from this study will be used to: Demonstrate the impact of STEADI and different components of STEADI on falls and fall injuries in a primary care setting and improve the implementation of STEADI in a primary care setting. There are no costs to the respondents other than their time. The total estimated annualized burden hours is 3,836. study period and screen as high risk for falls at the selected primary care clinics implementing the STEADI fall prevention initiative. The study population for the process evaluation will include the clinical implementation staff at the selected clinics where the intervention will take place (physicians, physician assistants/nurse practitioners, study research nurses, and practice or operations manager). Two data collection methods will be used; the CDC’s Stay Independent Fall Risk Screener will be administered to older adult patients at selected primary care clinics to determine which older adults are at high risk for a fall. Those who screen at high risk will be assigned, based on clinic attended and week of attendance, to one of three study arms. Patient surveys will be used to determine whether or not these patients experience a fall during the study period, are treated for a fall, and/or use any fall prevention strategies throughout the study period. Four surveys will be administered to each patient during a 12-month period: One baseline survey and three follow-up surveys. Older adults will also be asked to keep track of their falls in a monthly falls diary, so ESTIMATED ANNUALIZED BURDEN HOURS Total burden (hours) Form name Patient ............................................... Stay Independent Fall Risk Screener. Patient Consent Form ...................... Patient Baseline Survey ................... Patient Follow-up Survey ................. Patient Falls Diary ............................ Nurse Interview Guide/Consent ....... Provider Interview Guide/Consent ... 5,093 1 10/60 849 * 1,333 1,000 896 896 1 3 1 1 3 12 1 1 12/60 15/60 15/60 10/60 1 1 267 250 672 1,792 1 3 Operations Manager Guide/Consent 2 1 1 2 ........................................................... ........................ ........................ ........................ 3,836 Nurse ................................................. Physician/Physician Assistants/ Nurse Practitioners. Clinic operations Manager ................ Total ........................................... Jeffrey M. Zirger, Lead, Information Collection Review Office Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–10838 Filed 5–23–19; 8:45 am] BILLING CODE 4163–19–P khammond on DSKBBV9HB2PROD with NOTICES Average burden per response (hours) Number of responses per respondent Number of respondents Type of respondent DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR); Correction Notice is hereby given of a change in the meeting of the Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR); April 24 2019, 10:30 a.m. to 5:00 p.m., EDT; April 25, 2019, 8:30 a.m. to 3:00 p.m., EDT which was published in the Federal Register on VerDate Sep<11>2014 18:10 May 23, 2019 Jkt 247001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 March 15, 2019 Volume 84, Number 51, pages 9525. The meeting date, time, and agenda should read as follows: This is a one day meeting on April 24, 2019, 8:30 a.m. to 4:00 p.m. EDT. Matters To Be Considered: The agenda will include: (1) OPHPR Updates from Director, (2) OPHPR Interval Updates from Division Directors, (3) Report from the Biological Agent Containment Working Group (BACWG), (4) Update on the response to the Ebola outbreak in the Democratic Republic of Congo (DRC). FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and E:\FR\FM\24MYN1.SGM 24MYN1 24152 Federal Register / Vol. 84, No. 101 / Friday, May 24, 2019 / Notices Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop D–44, Atlanta, Georgia 30329, Telephone: (404) 639–7450; Fax: (404) 471–8772; Email: OPHPR.BSC.Questions@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–10871 Filed 5–23–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP, STAC); Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of Charter Renewal. AGENCY: This gives notice that under Public Law 111–347 (the James Zadroga 9/11 Health and Compensation Act of 2010), as amended by Public Law 114– 113, and the Federal Advisory Committee Act (Pub. L. 92–463) of October 6, 1972, the World Trade Center Health Program Scientific/Technical Advisory Committee, the Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through May 12, 2021. FOR FURTHER INFORMATION CONTACT: Tania Carreo´n-Valencia, Ph.D., Designated Federal Officer, WTCHP STAC, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road NE, MS: R– 12, Atlanta, GA 30329; telephone (513) 841–4515; email TCarreonValencia@ cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and khammond on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:10 May 23, 2019 Jkt 247001 Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–10873 Filed 5–23–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Agency Forms Undergoing Paperwork Reduction Act Review Proposed Project National Syndromic Surveillance Program (OMB Control No. 0920–0824, Exp. 5/31/2019)—Revision—Center for Surveillance, Epidemiology and Laboratory Services (CSELS), Centers for Disease Control and Prevention (CDC). In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled National Syndromic Surveillance Program— Revision to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on March 20, 2019 to obtain comments from the public and affected agencies. CDC received one comment related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy Background and Brief Description Syndromic surveillance uses syndromic data and statistical tools to detect, monitor, and characterize unusual activity for further public health investigation or response. Syndromic data include electronic extracts of electronic health records (EHRs) from patient encounter data from emergency departments, urgent care, ambulatory care, and inpatient healthcare settings, as well as pharmacy and laboratory data. Though these data are being captured for different purposes, they are monitored in near real-time as potential indicators of an event, a disease, or an outbreak of public health significance. On the national level, these data are used to improve nationwide situational awareness and enhance responsiveness to hazardous events and disease outbreaks to protect America’s health, safety, and security. The BioSense Program was created by congressional mandate as part of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 and was launched by the CDC in 2003. The BioSense Program has since been expanded into the National Syndromic Surveillance Program (NSSP) which promotes and advances development of a syndromic surveillance system for the timely exchange of syndromic data. CDC requests a three-year approval for a Revision for NSSP (OMB Control No. 0920–0824, Expiration Date 5/31/2019). This Revision includes a new request for approval to receive onboarding data from state, local and territorial public health departments about healthcare facilities in their jurisdiction. NSSP features the BioSense Platform and a collaborative Community of Practice. The BioSense Platform is a secure integrated electronic health information system that CDC provides, primarily for use by state, local and Centers for Disease Control and Prevention [30Day–19–0824] PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 84, Number 101 (Friday, May 24, 2019)]
[Notices]
[Pages 24151-24152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10871]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Public Health 
Preparedness and Response (BSC, OPHPR); Correction

    Notice is hereby given of a change in the meeting of the Board of 
Scientific Counselors, Office of Public Health Preparedness and 
Response (BSC, OPHPR); April 24 2019, 10:30 a.m. to 5:00 p.m., EDT; 
April 25, 2019, 8:30 a.m. to 3:00 p.m., EDT which was published in the 
Federal Register on March 15, 2019 Volume 84, Number 51, pages 9525.
    The meeting date, time, and agenda should read as follows: This is 
a one day meeting on April 24, 2019, 8:30 a.m. to 4:00 p.m. EDT.
    Matters To Be Considered: The agenda will include: (1) OPHPR 
Updates from Director, (2) OPHPR Interval Updates from Division 
Directors, (3) Report from the Biological Agent Containment Working 
Group (BACWG), (4) Update on the response to the Ebola outbreak in the 
Democratic Republic of Congo (DRC).

FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and

[[Page 24152]]

Public Health Practice, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop D-44, Atlanta, Georgia 30329, Telephone: 
(404) 639-7450; Fax: (404) 471-8772; Email: 
[email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-10871 Filed 5-23-19; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.